Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Immuneed logo — Select the most promising drug candidates with us and accele...

Immuneed

Select the most promising drug candidates with us and accelerate your path to drug development.

Founded 2014 Sweden Sweden 12 employees Seed Total: $4.30M Biotechnology, Health Care +1

General Information

Company Name Immuneed
Founded Year 2014
Location Sweden Sweden +1
Employees 12
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Seed
Social

Get notified when Immuneed moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Immuneed

Immuneed is a biotechnology startup based in Sweden, founded in 2014 with the slogan "Select the most promising drug candidates with us and accelerate your path to drug development." The company specializes in enabling firms at the forefront of science to invest in the right drug candidate. Immuneed's unique ex-vivo test system ID.Flow, combined with a highly competent team, provides exclusive insights into the safety of their clients' most promising drug candidates. Their last investment round, a kr4.30M Seed Round, was secured on 13 September 2016 with Almi Invest being the investor. The startup operates within the Biotechnology, Health Care, and Pharmaceutical industries. Immuneed's capabilities in identifying the safest and most promising drug candidates make it an attractive prospect for venture capital investment.

Taxonomy: Immunotoxicity, Drug development, Monoclonal antibodies, Contract research organization, Safety Assessment, Functional studies, Biologics, Proteins, Peptides, Virus, Small molecules, Innate Immunity, Immune profiling, Immuno-oncology, Platelet activation

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round •••••• 1
Investor
13 Sep 2016

Immuneed Alternatives & Competitors

Immuneed vs
Erbagil s.r.l. - Export department
Erbagil s.r.l. - Export department Italy

Without drug more than a drug

2 employees
Immuneed vs
N1 Life
N1 Life United States

Drug Delivery Innovation for Drug Development Revolution

Seed
10 employees
Biotechnology, Life Sciences
Immuneed vs
Synens
Synens France

Intelligent Drug Screening

1 employees
Medical Devices

FAQ About Immuneed

Select the most promising drug candidates with us and accelerate your path to drug development.
Immuneed was founded in 2014.
Immuneed is headquartered in Sweden.
Immuneed operates in the following industries: Biotechnology, Health Care, Pharmaceutical.
Immuneed has approximately 12 employees.
Immuneed has completed 1 funding round, raising a total of $4.30M. The latest funding stage is Seed.
Top alternatives and competitors to Immuneed include Erbagil s.r.l. - Export department, N1 Life, Synens, CaroCure Discovery Solutions, Evotec. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Immuneed and Erbagil s.r.l. - Export department are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Immuneed and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes